Skip to main content
Premium Trial:

Request an Annual Quote

Bruce Neri, Clyde Shoresas, Peter O Hanley, Ray Cummings, Mark Kay, Bernard Kolodziej, John Linnan

Premium

Prometheus Laboratories said this week that it has appointed Bruce Neri as vice president of diagnostics R&D, and Clyde Shoresas vice president of marketing.

Neri joins Prometheus from Third Wave Technologies, where he was most recently senior vice president of R&D for its Invader technology. Prior to joining Third Wave, he was vice president of DNA probe development at Becton Dickinson. Shores served in various executive roles at companies such as Amgen and Abbott.


AVI BioPharma has appointed Peter O’Hanley as senior vice president of clinical development and regulatory affairs, and Ray Cummings as vice president of business development, the company said this week.

O’Hanley comes to the company from Maxygen, where he was vice president of clinical development. He received his PhD and MD degrees from the Medical University of South Carolina, and obtained his MPH at the University of California, Berkeley.

Cummings comes to AVI from Cummings Consulting, where he was founder and president. Before founding the firm, he was a vice president of business development at Aradigm. Cummings received his MBA from the University of California, Berkeley. He also received an MS from Harvard University in biochemistry and molecular biology, and a BS in biological sciences from Stanford University.


CombiMatrix has named Mark Kay to its scientific advisory board. Kay is professor in the departments of pediatrics and genetics, and the director of the program in human gene therapy at the Stanford University School of Medicine.


Bruker AXS has promoted Bernard Kolodziej to vice president of finance. Kolodziej was originally hired by Bruker AXS in 1997 and has been CFO for the European operations of Bruker AXS since January 1999. Before joining the company, he held several positions in operations and finance with the Siemens’ X-ray business. He has a master’s degree in business administration, finance, and production engineering from the University of Karlsruhe in Germany.


Agencourt Bioscience this week said it has appointed John Linnan as vice president of sales. Linnan will lead Agencourt's worldwide sales force, which has recently expanded with the addition of three US sales representatives and partnerships with two new international distributors.

Linnan comes to Agencourt from Applied Biosystems, where he was the district sales manager for New England. He has a BA in marketing and management from James Madison University.

Filed under

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.